United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News OncoVerity accelerates AML treatment with Series A extension OncoVerity, a leader in integrating bioinformatics with oncology drug development, has closed a Series A extension financing round,… byPallavi MadhirajuNovember 23, 2024